BMRN Biomarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified
BMRN Biomarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome ReNU syndrome was discovered in 2024 and there are no Medicines approved for the condition Collaboration combines Biomarin's leadership in genetic Medicines with n-Lorem's pioneering antisense expertise
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.